Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 4408
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?

Chakraborty Dwaipayan Sarathi, Hazra Avijit, Sil Amrita, Pain Shantasil

Year : 2019| Volume: 8| Issue : 10 | Page no: 3173-3178

   This article has been cited by
1 Revitalizing the local anesthetic effect of Mebeverine hydrochloride via encapsulation within ethosomal vesicular system
Azza A. Hasan,Rasha M. Samir,Samir S. Abu-Zaid,Amr S. Abu Lila
Colloids and Surfaces B: Biointerfaces. 2020; : 111208
[Pubmed]  [Google Scholar] [DOI]
2 An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome
Taraneh Mousavi,Shekoufeh Nikfar,Mohammad Abdollahi
Expert Opinion on Drug Metabolism & Toxicology. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article